Metacam
Active substance
ATC code
Species
Dogs
Indications
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Dose to be administered and administration route
Oral use.
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of the veterinary medicinal product can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
To be administered orally either mixed with food or directly into the mouth.
The suspension can be given using either the drop dispenser of the bottle (for very small breeds) or the measuring syringe provided in the package.
Dosing procedure using the drop dispenser of the bottle:
Initial dose: 4 drops/kg body weight
Maintenance dose: 2 drops/kg body weight.
Dosing procedure using the measuring syringe:
The syringe fits onto the drop dispenser of the bottle and has a kg-body weight scale which corresponds to the maintenance dose. Thus for initiation of the therapy on the first day, twice the maintenance volume will be required.
Alternatively therapy may be initiated with Metacam 5 mg/ml solution for injection.
A clinical response is normally seen within 3 to 4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Particular care should be taken with regard to the accuracy of dosing. To ensure a correct dosage, body weight should be determined as accurately as possible. The use of suitably calibrated measuring equipment is recommended. Shake well before use.
Avoid introduction of contamination during use.
Adverse reactions
Dogs:
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Appetite loss1, lethargy1 Vomiting1, diarrhoea1, blood in faeces1,2, haemorrhagic diarrhoea1, haematemesis1, gastric ulcer, small intestine ulcer1 Elevated liver enzymes1 Renal failure1 |
1 These side effects occur generally within the first treatment week and are in most casestransient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
2 Occult
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 04491/5017 |
EAN | 5012917010053 |